Singapore grants interim approval for Novavax's COVID-19 vaccine | Inquirer News

Singapore grants interim approval for Novavax’s COVID-19 vaccine

/ 01:18 PM February 14, 2022


 woman holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in front of displayed Novavax logo in this illustration taken, October 30, 2020. REUTERS FILE PHOTO

SINGAPORE —  Singapore’s Health Sciences Authority (HSA) said on Monday it has granted an interim authorization for Novavax’s COVID-19 vaccine.

The first batch of the Nuvaxovid vaccine is expected to arrive in Singapore in the next few months, the HSA said.




Germans pin hopes on Novavax moving the needle among anti-vaxxers

South Korea authorizes use of Novavax COVID-19 vaccine

Novavax says COVID vaccine triggers immune response to Omicron variant

Novavax says COVID-19 shot 80% effective in adolescent study

Novavax COVID-19 vaccine gets emergency use approval in PH

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Health, Novavax, Singapore

© Copyright 1997-2024 | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.